keyword
MENU ▼
Read by QxMD icon Read
search

Menopausal symptoms

keyword
https://www.readbyqxmd.com/read/29034324/a-review-of-epidemiologic-studies-of-the-health-of-gulf-war-women-veterans
#1
Steven S Coughlin, Maxine Krengel, Kimberly Sullivan, Penny F Pierce, Vahé Heboyan, Lt Col Candy Wilson
INTRODUCTION: In the 25 years since the 1990-1991 Gulf War (GW), studies have evaluated Gulf War Illness (GWI), sometimes referred to as medically unexplained multi symptom illness, and other medical and neurological conditions in women GW veterans. MATERIALS AND METHODS: In this article, we review epidemiologic studies of the health of women who served in the 1990-1991 GW based upon bibliographic searches in PubMed and CINAHL with relevant search terms through September 2015...
2017: Journal of Environment and Health Sciences
https://www.readbyqxmd.com/read/29033611/stable-ischemic-heart-disease-in-women-current-perspectives
#2
REVIEW
Fatima Samad, Anushree Agarwal, Zainab Samad
Cardiovascular disease is the leading cause of death in women accounting for 1 in every 4 female deaths. Pathophysiology of ischemic heart disease in women includes epicardial coronary artery, endothelial dysfunction, coronary vasospasm, plaque erosion and spontaneous coronary artery dissection. Angina is the most common presentation of stable ischemic heart disease (SIHD) in women. Risk factors for SIHD include traditional risks such as older age, obesity (body mass index [BMI] >25 kg/m(2)), smoking, hypertension, dyslipidemia, cerebrovascular and peripheral vascular disease, sedentary lifestyle, family history of premature coronary artery disease, metabolic syndrome and diabetes mellitus, and nontraditional risk factors, such as gestational diabetes, insulin resistance/polycystic ovarian disease, pregnancy-induced hypertension, pre-eclampsia, eclampsia, menopause, mental stress and autoimmune diseases...
2017: International Journal of Women's Health
https://www.readbyqxmd.com/read/29031868/prevalence-and-risk-factors-for-chronic-venous-disease-in-the-general-russian-population
#3
Igor A Zolotukhin, Evgeny I Seliverstov, Yuri N Shevtsov, Ilona P Avakiants, Aleksey S Nikishkov, Andrey M Tatarintsev, Alexander I Kirienko
OBJECTIVE/BACKGROUND: The aim was to establish the prevalence of chronic venous disease (CVD) and its risk factors in the general population. METHODS: This was a population based, cross sectional study. In total, 703 residents aged > 18 years from the rural community of Kryukovo (Central Russia) were enrolled. Medical history was taken and clinical examination performed, documenting venous signs/symptoms. The CEAP classification of the most affected limb was used...
October 11, 2017: European Journal of Vascular and Endovascular Surgery
https://www.readbyqxmd.com/read/29024840/a-case-report-of-endometriosis-presenting-as-an-acute-small-bowel-obstruction
#4
Daniel L Chan, Dorothy Chua, Praveen Ravindran, Marisol Perez Cerdeira, Isabella Mor
INTRODUCTION: Endometriosis is a common and benign condition that causes significant morbidity to women of childbearing age. It uncommonly affects the gastrointestinal tract and rarely manifests as an acute small bowel obstruction. PRESENTATION OF CASE: A 46-year old female presented to the emergency department with signs and symptoms consistent with an acute small bowel obstruction. She had a paucity of background surgical history, having only had a laparoscopic cholecystectomy...
October 5, 2017: International Journal of Surgery Case Reports
https://www.readbyqxmd.com/read/28994639/migraine-menopause-and-hormone-replacement-therapy
#5
E Anne MacGregor
Perimenopause marks a period of increased migraine prevalence in women and many women also report troublesome vasomotor symptoms. Migraine is affected by fluctuating estrogen levels with evidence to support estrogen 'withdrawal' as a trigger of menstrual attacks of migraine without aura, while high estrogen levels can trigger migraine aura. Maintaining a stable estrogen environment with estrogen replacement can benefit estrogen-withdrawal migraine particularly in women who would also benefit from relief of vasomotor symptoms...
January 1, 2017: Post Reproductive Health
https://www.readbyqxmd.com/read/28985473/red-clover-aryl-hydrocarbon-receptor-ahr-and-estrogen-receptor-er-agonists-enhance-genotoxic-estrogen-metabolism
#6
Tareisha L Dunlap, Caitlin E Howell, Nita Mukand, Shao-Nong Chen, Guido F Pauli, Birgit Maria Dietz, Judy L Bolton
Many women consider botanical dietary supplements (BDSs) as safe alternatives to hormone therapy for menopausal symptoms. However, the effect of BDSs on breast cancer risk is largely unknown. In the estrogen chemical carcinogenesis pathway, P450 1B1 metabolizes estrogens to 4-hydroxylated catechols, which are oxidized to genotoxic quinones that initiate and promote breast cancer. In contrast, P450 1A1 catalyzed 2-hydroxylation represents a detoxification pathway. The current study evaluated the effects of red clover, a popular BDS used for women's health, and its isoflavones, biochanin A (BA), formononetin (FN), genistein (GN), and daidzein (DZ), on estrogen metabolism...
October 6, 2017: Chemical Research in Toxicology
https://www.readbyqxmd.com/read/28984773/ovarian-torsion-of-mixed-epithelial-tumor-misdiagnosed-as-a-malignancy-in-postmenopausal-woman-a-case-report
#7
Hyeji Jeon, Aeli Ryu, Hui-Gyeong Seo, Si-Hyong Jang
RATIONALE: Adnexal torsion is 1 of the most common emergency gynecological disease. It is more often diagnosed in reproductive age, but rarely in postmenopausal women. The clinical symptoms of adnexal torsion are nonspecific in postmenopausal women. Epithelial ovarian tumors are common in adults, and the risk of malignancy increases with age, especially after menopause. So, it is difficult to diagnose adnexal torsion precisely compared with reproductive women, and most cases of adnexal torsion with postmenopausal women are diagnosed as a malignancy preoperatively...
October 2017: Medicine (Baltimore)
https://www.readbyqxmd.com/read/28982960/management-of-endocrine-disease-flushing-current-concepts
#8
REVIEW
Isabel Huguet, Ashley Grossman
OBJECTIVE: Flushing can be defined as a sensation of warmth accompanied by erythema that most commonly is seen on the face and which occurs in episodic attacks. Such a problem can be clinically problematic, since many conditions and drugs can be related to flushing, and while often there appears to be no underlying organic disease, it is important to exclude disorders since they may be life-threatening conditions. DESIGN AND METHODS: We performed a search in MEDLINE using the terms 'flushing' in combination with 'carcinoid syndrome', 'pheochromocytoma', 'mastocytosis', 'menopausal hot flush' and 'treatment'...
November 2017: European Journal of Endocrinology
https://www.readbyqxmd.com/read/28982486/weight-gain-in-women-at-midlife-a-concise-review-of-the-pathophysiology-and-strategies-for-management
#9
REVIEW
Ekta Kapoor, Maria L Collazo-Clavell, Stephanie S Faubion
Weight gain accompanied by an increased tendency for central fat distribution is common among women in midlife. These changes are a result of aging, decreasing estrogen levels after menopause, and other unique influences in menopausal women that interfere with the adoption of healthy lifestyle measures. Central obesity, in particular, results in several adverse metabolic consequences, including dysglycemia, dyslipidemia, hypertension, and cardiovascular disease. Given that cardiovascular disease is the leading cause of death in postmenopausal women, the importance of weight management in midlife cannot be overemphasized...
October 2017: Mayo Clinic Proceedings
https://www.readbyqxmd.com/read/28980489/fsh-to-estradiol-ratio-can-be-used-as-screening-method-for-mild-cognitive-impairment-in-postmenopausal-women
#10
A Hestiantoro, M Wiwie, A Shadrina, N Ibrahim, J S Purba
OBJECTIVE: To determine the role of anthropometric measurement, menopausal symptoms and biochemical marker changes as screening methods for mild cognitive impairment (MCI) in postmenopausal women Methods: A cross-sectional study included 282 postmenopausal women in Jakarta, further classified into two groups, with and without MCI. Some related variables such as age, body mass index (BMI), duration of menopause, vasomotor symptoms, hormone levels such as follicle stimulating hormone (FSH), luteinizing hormone, leptin, estradiol, and cognitive status, were assessed and analyzed...
October 5, 2017: Climacteric: the Journal of the International Menopause Society
https://www.readbyqxmd.com/read/28975014/the-relative-burden-of-menopausal-and-postmenopausal-symptoms-versus-other-major-conditions-a-retrospective-analysis-of-the-medical-expenditure-panel-survey-data
#11
Annlouise R Assaf, Andrew G Bushmakin, Nina Joyce, Michael J Louie, Michael Flores, Margaret Moffatt
BACKGROUND: The direct costs associated with menopausal and postmenopausal symptoms (hereafter "menopausal symptoms") may include the costs of physician and emergency department visits, medications, laboratory testing, and the management of side effects. However, much remains unknown about the costs related to menopausal symptoms, including how they compare with the costs of other diseases that are common among menopausal women. OBJECTIVE: To compare the economic burden of menopausal symptoms with other select prevalent chronic conditions among a nationally representative sample of US menopausal women aged 45 to 65 years...
September 2017: American Health & Drug Benefits
https://www.readbyqxmd.com/read/28969624/why-women-choose-compounded-bioidentical-hormone-therapy-lessons-from-a-qualitative-study-of-menopausal-decision-making
#12
Jennifer Jo Thompson, Cheryl Ritenbaugh, Mark Nichter
BACKGROUND: In recent years, compounded bioidentical hormone therapy (CBHT) has emerged as a popular alternative to manufactured, FDA approved hormone therapy (HT)-despite concerns within the medical community and the availability of new FDA approved "bioidentical" products. This study aims to characterize the motivations for using CBHT in a U.S. sample of ordinary midlife women. METHODS: We analyze data collected from 21 current and former users of CBHT who participated in a larger qualitative study of menopausal decision-making among U...
October 2, 2017: BMC Women's Health
https://www.readbyqxmd.com/read/28969534/perioperative-management-of-female-hormone-medications
#13
Lynsey A Seim, Joan M Irizarry-Alvarado
BACKGROUND: No clear guideline exists for the management of female hormone therapy in the perioperative period. Besides oral contraceptives (OCPs), hormone medications have been prescribed to treat cancer, osteoporosis, and menopausal symptoms. Since the introduction of OCPs in the 1960s, the thromboembolic risk associated with these medications has been studied and alterations have been made in the hormone content. The continuation of hormone therapy in the perioperative period and its possible interactions with commonly used anesthetic agents are important information for all perioperative health care providers...
September 26, 2017: Current Clinical Pharmacology
https://www.readbyqxmd.com/read/28969213/severity-and-frequency-of-menopausal-symptoms-in-middle-aged-women-rasht-iran
#14
Marzieh Masjoudi, Marjan Akhavan Amjadi, Ehsan Kazem Nezhad Leyli
INTRODUCTION: Menopause is a natural event in women's life. Some studies have shown that, these symptoms can lead to low quality of life. AIM: To identify the severity and frequency of menopausal symptoms in different stages of menopause, in a group of middle aged women. MATERIALS AND METHODS: This cross-sectional study was conducted on 646 women aged 45-60 years in Rasht, Iran, who were included in the study by convenience sampling method...
August 2017: Journal of Clinical and Diagnostic Research: JCDR
https://www.readbyqxmd.com/read/28968302/a-conversation-about-hormone-therapy-is-there-an-appropriate-dose-route-and-duration-of-use
#15
(no author information available yet)
The North American Menopause Society (NAMS) held the 3rd Utian Translational Symposium on October 4, 2016, in Orlando, Florida, to answer questions about the benefits and risks of hormone therapy (HT) for postmenopausal women. This report is a record of the proceedings of that symposium.The maxim about HT for the past 15 years since the publication of the initial results of the Women's Health Initiative (WHI) has been to prescribe the "lowest dose for the shortest period of time." With new clinical trials, observational data, and further analysis of the WHI and the cumulative 13 years' follow-up, it was time to hold a conversation about the state of the evidence and recommendations for HT dose, route, and duration of use...
October 2, 2017: Menopause: the Journal of the North American Menopause Society
https://www.readbyqxmd.com/read/28966563/anxiety-disorders-among-women-a-female-lifespan-approach
#16
Liisa Hantsoo, C Neill Epperson
Anxiety symptoms may present differently between women and men, and at different points in the female lifespan. The female lifespan includes distinct epochs of hormonal function, including puberty, the premenstruum, in some women pregnancy or postpartum, and the menopausal transition. These stages give rise to important treatment considerations when treating anxiety in women. When making assessments, the clinician should consider reproductive events and hormonal status, as well as sex differences in anxiety presentation...
2017: Focus: Journal of Life Long Learning in Psychiatry
https://www.readbyqxmd.com/read/28964928/evaluation-of-estrogenic-potency-of-a-standardized-hops-extract-on-mammary-gland-biology-and-on-mnu-induced-mammary-tumor-growth-in-rats
#17
Annekathrin M Keiler, Dana Macejova, Birgit M Dietz, Judy L Bolton, Guido F Pauli, Shao-Nong Chen, Richard B van Breemen, Dejan Nikolic, Florian Goerl, Michael H Muders, Oliver Zierau, Günter Vollmer
Supplements with estrogenic activities are intensively investigated as potential alternatives for the treatment of menopausal symptoms. These investigations include studies on their safety regarding potential breast cancer risks. Therefore, the aim of this study was to assess whether or not a standardized hops (Humulus lupulus) extract, containing 0.42% of the estrogenic flavanone, 8-prenylnaringenin, would stimulate growth of methyl-nitrosourea (MNU) induced mammary cancer in ovariectomized (OVX) Sprague-Dawley (SD) rats or would impact on the proliferative activity within the normal mammary gland of Wistar rats...
September 27, 2017: Journal of Steroid Biochemistry and Molecular Biology
https://www.readbyqxmd.com/read/28962557/characteristics-of-cervical-disease-among-symptomatic-women-with-histopathological-sample-at-hawassa-university-referral-hospital-southern-ethiopia
#18
Gemechu Ameya, Fekade Yerakly
BACKGROUND: Cervical cancer is one of the most common cancers of women in developing countries. It is also eminent cause of mortality and morbidity in women worldwide. Symptoms usually develop when the cancer has become invasive and invade nearby tissue. This has significant effect on treatment of cases in area where there is limited awareness. The aim of this study is to describe cervical disease among symptomatic women with a histhological sample at Hawassa University referral hospital, southern Ethiopia...
September 29, 2017: BMC Women's Health
https://www.readbyqxmd.com/read/28959241/prophylactic-supplementation-of-bifidobacterium-longum-5-1a-protects-mice-from-ovariectomy-induced-exacerbated-allergic-airway-inflammation-and-airway-hyperresponsiveness
#19
Eduardo Mendes, Beatriz G Acetturi, Andrew M Thomas, Flaviano Dos S Martins, Amanda R Crisma, Gilson Murata, Tárcio T Braga, Niels O S Camâra, Adriana L Dos S Franco, João C Setubal, Willian R Ribeiro, Claudete J Valduga, Rui Curi, Emmanuel Dias-Neto, Wothan Tavares-de-Lima, Caroline M Ferreira
Asthma is a chronic inflammatory disease that affects more females than males after puberty, and its symptoms and severity in women change during menstruation and menopause. Recently, evidence has demonstrated that interactions among the microbiota, female sex hormones, and immunity are associated with the development of autoimmune diseases. However, no studies have investigated if therapeutic gut microbiota modulation strategies could affect asthma exacerbation during menstruation and menopause. Here we aimed to examine the preventive effects of a probiotic, Bifidobacterium longum 5(1A), on airway inflammation exacerbation in allergic ovariectomized mice...
2017: Frontiers in Microbiology
https://www.readbyqxmd.com/read/28953214/clinical-trials-in-menopause
#20
Kathryn I Marko, James A Simon
OBJECTIVE: Clinical trials in menopause have undergone much scrutiny over the years. This has led to significant shifts in the treatment of symptomatic menopause and a substantial impact on women. We aim to delineate the key studies contributing to this controversy and highlight new directions specifically related to menopausal hormone therapy (HT) and vascular disease risk. METHODS: We performed a search of sentinel studies delineating the risks and benefits of HT in otherwise healthy postmenopausal women...
September 25, 2017: Menopause: the Journal of the North American Menopause Society
keyword
keyword
47383
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"